Altimmune (ALT) Shares Outstanding (Entity) (2010 - 2018)
Altimmune (ALT) Shares Outstanding (Entity) (2010 - 2018) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 254.16 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 200.18 Mn |
| 10 | Altimmune | 346.63 Mn | 346.63 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 2.80 Mn |
| Sep 30, 2018 | 1.32 Mn |
| Jun 30, 2018 | 950,919.00 |
| Mar 31, 2018 | 742,314.00 |
| Dec 31, 2017 | 426,794.00 |
| Sep 30, 2017 | 521,702.00 |
| Jun 30, 2017 | 408,149.00 |
| Mar 31, 2017 | 229,361.00 |
| Dec 31, 2016 | 225,732.00 |
| Sep 30, 2016 | 221,388.00 |
| Jun 30, 2016 | 215,931.00 |
| Mar 31, 2016 | 214,794.00 |
| Dec 31, 2015 | 214,585.00 |
| Sep 30, 2015 | 214,508.00 |
| Jun 30, 2015 | 213,019.00 |
| Mar 31, 2015 | 212,227.00 |
| Dec 31, 2014 | 211,990.00 |
| Sep 30, 2014 | 211,224.00 |
| Jun 30, 2014 | 185,067.00 |
| Mar 31, 2014 | 179,228.00 |